CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Louisville, Kentucky, United States and 93 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Louisville, Kentucky, United States and 833 other locations
with end stage kidney disease (ESKD) undergoing maintenance dialysis....
Phase 2, Phase 3
Louisville, Kentucky, United States and 356 other locations
The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA...
Phase 3
Louisville, Kentucky, United States and 135 other locations
(IG) for hemodialysis (HD) access in patients with end-stage renal disease (ESRD). The primary study endpoints are:Primary Effectiveness End...
Louisville, Kentucky, United States and 10 other locations
implicated in the inflammatory chemokine environment of chronic disease. The purpose of this pivotal randomized double-blind study is to inv...
Phase 3
Louisville, Kentucky, United States and 219 other locations
The objectives of this study are to evaluate the safety and efficacy of ravulizumab administered by intravenous (IV) infusion compared to placebo and...
Phase 2
Louisville, Kentucky, United States and 63 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...
Phase 3
Louisville, Kentucky, United States and 370 other locations
To determine the long-term (approximately 2 years) nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blo...
Phase 3
Louisville, Kentucky, United States and 161 other locations
The goal of this research study is to establish chimerism and avoid graft-versus-host disease in patients with kidney failure allow...
Phase 1, Phase 2
Louisville, Kentucky, United States and 1 other location
Clinical trials
Research sites
Resources
Legal